Varun Beverages announces 2:5 stock split, interim dividend of Rs 1.25 per share
Varun Beverages, PepsiCo’s franchise partner, declared a stock split in the ratio of 2:5 and announced an interim dividend of Rs 1.25 per share. The company’s June quarter results showed a 26% year-over-year increase in profit, amounting to Rs 1,261.83 crore, with revenue growing by 28%.
Akums Drugs and Pharma IPO opens for subscription. Should you bid?
Akums Drugs IPO Opens Today: Akums Drugs and Pharmaceuticals’ IPO, valued at Rs 1,857 crore, closed on August 1. The issue included Rs 680 crore in fresh shares and an offer for sale of 1.73 crore shares. Analysts recommended investors subscribe, citing the company’s established market presence and variety of clients as key strengths.
What is NPS Vatsalya? How parents and guardians can invest for minors in this scheme?
Hemant Rustagi discussed the new NPS Vatsalya scheme, highlighting that it adds another investment option for parents planning their children’s education. He noted the importance of understanding different investment options and their nuances. Rustagi emphasized flexibility and return potential when comparing NPS with other existing schemes for long-term financial goals.
The bar for PMS fund managers to please crorepati investors just got higher after Budget
Recent tax changes in the Union Budget have increased capital gains tax rates, complicating the task for PMS fund managers to generate higher post-tax returns compared to mutual funds. Despite a historical trend of outperforming mutual funds, PMS schemes now require higher annual returns to stay competitive. Long-term strategies are less impacted, while short-term focused […]
Ola Electric is The Indian Story and not just an Indian story; want to make sure investors make money long term: Bhavish Aggarwal
Bhavish Aggarwal and Harish Abichandani of Ola Electric Mobility discussed their aggressive IPO pricing and future plans. Aggarwal emphasized the company’s rapid growth in India’s EV sector. Abichandani stressed the importance of retail and institutional growth. They aim to make India a global EV hub through sustained R&D investment and anticipate strong market support.
Hot stocks: Brokerage view on BEL, HPCL, Colgate, ACC and MCX
UBS downgraded BEL to Neutral but raised the target price to Rs 340. They see positives factored into the stock, leaving little room for surprises, but remain cautiously optimistic about earnings and growth.
Market may be marginally disappointed with Q1 result season: Jitendra Sriram
“While the consensus earnings for FY2024-25 are in the low teens, we expect the growth to be more in 2H,” he said, explaining that elections and heat waves slowed down economic activities during the quarter.
Adani Energy set to raise up to $1 billion via QIP
This will be the first equity fundraising by an Adani Group company since Adani Enterprises called off its ₹20,000 crore follow-on public offer (FPO) in February last year after having raised the amount.
Big movers on D-Street: What should investors do with Adani Wilmar, DLF and RITES?
Sensex and Nifty reached intraday record highs but ended nearly flat ahead of a key US Fed decision. Adani Wilmar gained 6.04%, DLF rose 4.7%, and RITES jumped 14.2%. Experts provided stock recommendations for the upcoming trading day.
Akums Pharma placed at a vantage point in pharma growth
Akums Drugs &Pharma, a prominent contract development and manufacturing company in India, launched an ₹1,856-crore IPO with ₹680 crore in fresh issuance. Promoters reduced stakes, and proceeds will tackle debt and working capital. Generating ₹4,178 crore in FY24, Akums serves top pharma brands and stands strong in the expanding market.